美国冠状病毒死亡人数达到 250,000

美国冠状病毒死亡人数达到 250,000

The novel 新冠病毒 has claimed more than 250,000 American lives as of Wednesday evening, according to the latest estimates from Johns Hopkins University.

用 250,029 fatalities, 美国. has now recorded more virus deaths than any country in the world, followed by Brazil, India and Mexico, 数据显示.

The grim milestone comes as COVID-19 cases are surging across the country, 超过 11,359,803 illnesses reported to date. Texas and California lead the nation with the most cases, with the latter state imposing new restrictions in an effort to curb virus spread.

CLICK HERE FOR FULL CORONAVIRUS COVERAGE

The hopes of putting a stop to the coronavirus pandemic lay with two promising coronavirus vaccine candidates, developed by Moderna and Pfizer, 分别. Both have proven highly efficacious in late-stage clinical trials, with Dr. 安东尼·福西, the nation’s leading infectious disease expert, calling the resultstruly striking.

But as Moderna and Pfizer continue to gather the required two months’ worth of safety data needed for emergency approval from the U.S. Food and Drug Administration (美国食品药品管理局), surging infections due to public non-compliance continue to overwhelm hospitals and strain staff across the nation.

“Now we’re seeing more cases because there is not enough public health compliance,” Fox News medical contributor Dr. 马克·西格尔 告诉 狐狸 & 友人” on Monday. “And that’s a big problem for me when the hospitals start to get full.”

上个星期, COVID-19 hospitalizations in the U.S. reached a record high, with some states seeing hospitals reach capacity limits. In rural areas and small hospitals, in particular, medical administrators are scrambling to find enough nursing help.

HOW DO THE MODERNA AND PFIZER CORONAVIRUS VACCINES COMPARE?

Until a safe and effective vaccine is approved, health officials continue to urge face masks, physical distancing, hand hygiene and avoiding crowds where possible.

福克斯新闻’ Kayla Rivas and Talia Kaplan contributed to this report.

单击此处获取FOX新闻应用程序

发表评论

您的电子邮件地址不会被公开. 必需的地方已做标记 *

*